Bernard G. Lemieux
Montreal, QC H2X1R6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A Retrospective Study on Prognostic Factors and Systemic Treatments of Refractory Meningiomas.
Journal: Current oncology (Toronto, Ont.)
Published: July 30, 2025
Feasibility, safety and efficacy of intranasal fentanyl in the treatment of acute pain episodes among adults with sickle cell disease: A retrospective single-centre study.
Journal: British journal of haematology
Published: March 03, 2025
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.
Journal: Endocrine pathology
Published: December 06, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.
Journal: Endocrine pathology
Published: October 27, 2024
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects.
Journal: Journal of the Endocrine Society
Published: January 12, 2022
Adult Medulloblastoma Demographic, Tumor and Treatment Impact since 2006: A Canadian University Experience.
Journal: Current oncology (Toronto, Ont.)
Published: July 16, 2021
Endosonography-Guided Biopsy as a First Test in the Diagnosis of Lymphoma.
Journal: Seminars in thoracic and cardiovascular surgery
Published: June 10, 2021
The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.
The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.
Journal: Transplantation direct
Published: July 17, 2019
Procarbazine, lomustine and vincristine toxicity in low-grade gliomas.
Journal: Current oncology (Toronto, Ont.)
Published: March 07, 2018
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: December 08, 2016
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study.
Journal: Haematologica
Published: August 22, 2016
Last Updated: 09/26/2026